Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Toxins (Basel) ; 7(5): 1411-30, 2015 Apr 28.
Artículo en Inglés | MEDLINE | ID: mdl-25928133

RESUMEN

Aflatoxin biosynthesis in the filamentous fungus Aspergillus parasiticus involves a minimum of 21 enzymes, encoded by genes located in a 70 kb gene cluster. For aflatoxin biosynthesis to be completed, the required enzymes must be transported to specialized early and late endosomes called aflatoxisomes. Of particular significance, seven aflatoxin biosynthetic enzymes are P450/monooxygenases which catalyze reactions that can produce reactive oxygen species (ROS) as byproducts. Thus, oxidative reactions in the aflatoxin biosynthetic pathway could potentially be an additional source of intracellular ROS. The present work explores the hypothesis that the aflatoxin biosynthetic pathway generates ROS (designated as "secondary" ROS) in endosomes and that secondary ROS possess a signaling function. We used specific dyes that stain ROS in live cells and demonstrated that intracellular ROS levels correlate with the levels of aflatoxin synthesized. Moreover, feeding protoplasts with precursors of aflatoxin resulted in the increase in ROS generation. These data support the hypothesis. Our findings also suggest that secondary ROS may fulfill, at least in part, an important mechanistic role in increased tolerance to oxidative stress in germinating spores (seven-hour germlings) and in regulation of fungal development.


Asunto(s)
Aflatoxinas/biosíntesis , Aspergillus/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Aspergillus/efectos de los fármacos , Catalasa/metabolismo , Endosomas/metabolismo , Peróxido de Hidrógeno/farmacología , Oxidación-Reducción , Estrés Oxidativo , Superóxido Dismutasa/metabolismo
2.
J Invest Dermatol ; 132(6): 1681-8, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-22402442

RESUMEN

UVR is a major environmental risk factor for the development of melanoma. Here we describe a coupled DNA-damage tolerance (DDT) mechanism and G2-phase cell cycle checkpoint induced in response to suberythemal doses of UVR that is commonly defective in melanomas. This coupled response is triggered by a small number of UVR-induced DNA lesions incurred during G1 phase that are not repaired by nucleotide excision repair (NER). These lesions are detected during S phase, but rather than stalling replication, they trigger the DDT-dependent formation of single-stranded DNA (ssDNA) gaps. The ssDNA attracts replication protein A (RPA), which initiates ATR-Chk1 (ataxia telangiectasia and Rad3-related/checkpoint kinase 1) G2-phase checkpoint signaling, and colocalizes with components of the RAD18 and RAD51 postreplication repair pathways. We demonstrate that depletion of RAD18 delays both the resolution of RPA foci and exit from the G2-phase arrest, indicating the involvement of RAD18-dependent postreplication repair in ssDNA gap repair during G2 phase. Moreover, the presence of RAD51 and BRCA1 suggests that an error-free mechanism may also contribute to repair. Loss of the UVR-induced G2-phase checkpoint results in increased UVR signature mutations after exposure to suberythemal UVR. We propose that defects in the UVR-induced G2-phase checkpoint and repair mechanism are likely to contribute to melanoma development.


Asunto(s)
Replicación del ADN/genética , ADN de Cadena Simple/genética , Fase G2/efectos de la radiación , Melanoma/patología , Neoplasias Cutáneas/patología , Proteína Quinasa CDC2/metabolismo , Puntos de Control del Ciclo Celular/genética , Puntos de Control del Ciclo Celular/efectos de la radiación , Línea Celular Tumoral , Ciclina B1/metabolismo , Replicación del ADN/efectos de la radiación , Proteínas de Unión al ADN/fisiología , Células Epidérmicas , Epidermis/efectos de la radiación , Fase G1/genética , Fase G1/efectos de la radiación , Fase G2/genética , Humanos , Melanoma/genética , Mutación/genética , Mutación/efectos de la radiación , Fase S/genética , Fase S/efectos de la radiación , Neoplasias Cutáneas/genética , Rayos Ultravioleta/efectos adversos
3.
J Toxicol Environ Health A ; 65(16): 1161-80, 2002 Aug 23.
Artículo en Inglés | MEDLINE | ID: mdl-12167214

RESUMEN

The effects of vomitoxin (VT) on the binding activity of three transcription factors critical to pro-inflammatory cytokine regulation were assessed in the RAW 264.7 murine macrophage model by electrophoretic mobility shift assay (EMSA). When cells were treated with 100 to 250 ng/ml of VT, activator protein-1 (AP-1 binding) was increased after 2 and 8 h. This effect was potentiated when cells were coincubated with lipopolysaccharide (LPS) (synchronous model) but not when preincubated with LPS (delayed synchronous model). Supershift EMSA revealed that VT preferentially induced JunB, JunD, phosphorylated c-Jun, c-Fos, and Fra-2 binding activities of the AP-1 family. Nuclear factor kappaB (NF-kappaB) binding was increased at 2 and 8 h in cells subjected to synchronous and delayed synchronous VT exposure in the presence of LPS. Supershift EMSA indicated that the p-50 and c-Rel subunits of NF-kappaB/ Rel were specifically affected. Nuclear factor-IL6 (NF-IL6) binding was increased at 2 and 8 h with or without LPS in synchronous and delayed synchronous VT-exposure models. Here, the C/EBPbeta subunit was primarily involved in enhanced NF-IL6 binding. The capacity of VT to elevate binding of AP-1, NF-kappaB, and NF-IL6 may contribute to the VT-mediated cytokine up-regulation in vitro and in vivo. The observations that VT was active in synchronous and delayed synchronous models suggest that macrophages activated simultaneously or prior to toxin exposure were vulnerable to the effects of this trichothecene.


Asunto(s)
Proteína beta Potenciadora de Unión a CCAAT/efectos de los fármacos , Macrófagos Alveolares/efectos de los fármacos , FN-kappa B/efectos de los fármacos , Factor de Transcripción AP-1/efectos de los fármacos , Factores de Transcripción/efectos de los fármacos , Tricotecenos/toxicidad , Animales , Sitios de Unión , Proteína beta Potenciadora de Unión a CCAAT/metabolismo , Células Cultivadas , Ensayo de Cambio de Movilidad Electroforética , Macrófagos Alveolares/metabolismo , Ratones , FN-kappa B/metabolismo , Factor de Transcripción AP-1/metabolismo , Factores de Transcripción/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...